Learn More
Selleck Chemical LLC Gliocidin E5804-25MG

Supplier: Selleck Chemical LLC E580425MG
Gliocidin (SW106065) is a nicotinamide-mimetic prodrug that targets glioblastoma cells with an IC50 of 150 nM by exploiting a de novo purine synthesis vulnerability via indirect inhibition of IMPDH2 It readily crosses the BBB and can be used in the treatment of all malignant brain tumors
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.